BCR and posterior cortical atrophy: Based on this, we constructed a signature that can effectively predict the risk of BCR in PCa patients using ARGs, which has good predictive power for BCR risk (AUC=0.823), higher than other clinicopathological data such as PSA and Gleason scores (10, 11), and more accurate than other signatures (32, 33).